Literature DB >> 31375883

Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning.

Lorenzo Ugga1, Renato Cuocolo2, Domenico Solari3, Elia Guadagno4, Alessandra D'Amico1, Teresa Somma3, Paolo Cappabianca3, Maria Laura Del Basso de Caro4, Luigi Maria Cavallo3, Arturo Brunetti1.   

Abstract

PURPOSE: Pituitary adenomas are among the most frequent intracranial tumors. They may exhibit clinically aggressive behavior, with recurrent disease and resistance to multimodal therapy. The ki-67 labeling index represents a proliferative marker which correlates with pituitary adenoma aggressiveness. Aim of our study was to assess the accuracy of machine learning analysis of texture-derived parameters from pituitary adenomas preoperative MRI for the prediction of ki-67 proliferation index class.
METHODS: A total of 89 patients who underwent an endoscopic endonasal procedure for pituitary adenoma removal with available ki-67 labeling index were included. From T2w MR images, 1128 quantitative imaging features were extracted. To select the most informative features, different supervised feature selection methods were employed. Subsequently, a k-nearest neighbors (k-NN) classifier was employed to predict macroadenoma high or low proliferation index. Algorithm validation was performed with a train-test approach.
RESULTS: Of the 12 subsets derived from feature selection, the best performing one was constituted by the 4 highest correlating parameters at Pearson's test. These all showed very good (ICC ≥ 0.85) inter-observer reproducibility. The overall accuracy of the k-NN in the test group was of 91.67% (33/36) of correctly classified patients.
CONCLUSIONS: Machine learning analysis of texture-derived parameters from preoperative T2 MRI has proven to be effective for the prediction of pituitary macroadenomas ki-67 proliferation index class. This might aid the surgical strategy making a more accurate preoperative lesion classification and allow for a more focused and cost-effective follow-up and long-term management.

Entities:  

Keywords:  Machine learning; Magnetic resonance imaging; Pituitary adenoma

Mesh:

Substances:

Year:  2019        PMID: 31375883     DOI: 10.1007/s00234-019-02266-1

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  42 in total

1.  The "suprasellar notch," or the tuberculum sellae as seen from below: definition, features, and clinical implications from an endoscopic endonasal perspective.

Authors:  Matteo de Notaris; Domenico Solari; Luigi M Cavallo; Alfonso Iodice D'Enza; Joaquim Enseñat; Joan Berenguer; Enrique Ferrer; Alberto Prats-Galino; Paolo Cappabianca
Journal:  J Neurosurg       Date:  2011-12-23       Impact factor: 5.115

2.  An affinity method for the purification of mannose 6-phosphate receptor proteins (MPR 215) from rat tissues and goat liver.

Authors:  N S Kumar
Journal:  J Biochem Biophys Methods       Date:  1996-02-05

3.  Whole-volume apparent diffusion coefficient-based entropy parameters for assessment of gastric cancer aggressiveness.

Authors:  Song Liu; Huanhuan Zheng; Yujuan Zhang; Ling Chen; Wenxian Guan; Yue Guan; Yun Ge; Jian He; Zhengyang Zhou
Journal:  J Magn Reson Imaging       Date:  2017-05-04       Impact factor: 4.813

4.  Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia.

Authors:  Benita Tamrazi; Melike Pekmezci; Mariam Aboian; Tarik Tihan; Christine M Glastonbury
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

5.  Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.

Authors:  Shuaitong Zhang; Guidong Song; Yali Zang; Jian Jia; Chao Wang; Chuzhong Li; Jie Tian; Di Dong; Yazhuo Zhang
Journal:  Eur Radiol       Date:  2018-03-23       Impact factor: 5.315

Review 6.  Extended endoscopic endonasal approach to the midline skull base: the evolving role of transsphenoidal surgery.

Authors:  P Cappabianca; L M Cavallo; F Esposito; O De Divitiis; A Messina; E De Divitiis
Journal:  Adv Tech Stand Neurosurg       Date:  2008

7.  Clinical significance of Ki-67 labeling index in pituitary macroadenoma.

Authors:  Kyung-Il Paek; Seon-Hwan Kim; Shi-Hun Song; Seung-Won Choi; Hyeon-Song Koh; Jin-Young Youm; Youn Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 8.  The 2017 WHO classification of pituitary adenoma: overview and comments.

Authors:  Naoko Inoshita; Hiroshi Nishioka
Journal:  Brain Tumor Pathol       Date:  2018-04-23       Impact factor: 3.298

9.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

10.  Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images.

Authors:  Jianxing Niu; Shuaitong Zhang; Shunchang Ma; Jinfu Diao; Wenjianlong Zhou; Jie Tian; Yali Zang; Wang Jia
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

View more
  16 in total

Review 1.  Machine Learning in Pituitary Surgery.

Authors:  Vittorio Stumpo; Victor E Staartjes; Luca Regli; Carlo Serra
Journal:  Acta Neurochir Suppl       Date:  2022

Review 2.  Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis.

Authors:  Kelvin Koong; Veronica Preda; Anne Jian; Benoit Liquet-Weiland; Antonio Di Ieva
Journal:  Neuroradiology       Date:  2021-11-27       Impact factor: 2.804

Review 3.  Machine learning in neuro-oncology: toward novel development fields.

Authors:  Vincenzo Di Nunno; Mario Fordellone; Giuseppe Minniti; Sofia Asioli; Alfredo Conti; Diego Mazzatenta; Damiano Balestrini; Paolo Chiodini; Raffaele Agati; Caterina Tonon; Alicia Tosoni; Lidia Gatto; Stefania Bartolini; Raffaele Lodi; Enrico Franceschi
Journal:  J Neurooncol       Date:  2022-06-28       Impact factor: 4.506

4.  Radiomics analysis allows for precise prediction of silent corticotroph adenoma among non-functioning pituitary adenomas.

Authors:  Wenting Rui; Nidan Qiao; Yao Zhao; Zhenwei Yao; Yue Wu; Yong Zhang; Ababikere Aili; Zhaoyun Zhang; Hongying Ye; Yongfei Wang
Journal:  Eur Radiol       Date:  2021-11-27       Impact factor: 7.034

Review 5.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

6.  Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study.

Authors:  Alberto Conficoni; Paola Feraco; Diego Mazzatenta; Matteo Zoli; Sofia Asioli; Corrado Zenesini; Viscardo Paolo Fabbri; Martino Cellerini; Antonella Bacci
Journal:  Br J Radiol       Date:  2020-07-06       Impact factor: 3.039

7.  Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI.

Authors:  Renato Cuocolo; Lorenzo Ugga; Domenico Solari; Sergio Corvino; Alessandra D'Amico; Daniela Russo; Paolo Cappabianca; Luigi Maria Cavallo; Andrea Elefante
Journal:  Neuroradiology       Date:  2020-07-23       Impact factor: 2.804

8.  Radiomics Approach for Prediction of Recurrence in Non-Functioning Pituitary Macroadenomas.

Authors:  Yang Zhang; Ching-Chung Ko; Jeon-Hor Chen; Kai-Ting Chang; Tai-Yuan Chen; Sher-Wei Lim; Yu-Kun Tsui; Min-Ying Su
Journal:  Front Oncol       Date:  2020-12-18       Impact factor: 6.244

Review 9.  The Application of Artificial Intelligence and Machine Learning in Pituitary Adenomas.

Authors:  Congxin Dai; Bowen Sun; Renzhi Wang; Jun Kang
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

10.  A Nomogram for Preoperatively Predicting the Ki-67 Index of a Pituitary Tumor: A Retrospective Cohort Study.

Authors:  Xiangming Cai; Junhao Zhu; Jin Yang; Chao Tang; Feng Yuan; Zixiang Cong; Chiyuan Ma
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.